Where to meet us

We are attending conferences to meet with new investment opportunities.

Novo Nordisk Biotech Fund

Novo Nordisk Biotech Fund is the corporate venture fund of  Novo Nordisk A/S responsible for the company's venture capital activities.

We provide venture capital to venture companies possessing pioneering technologies and competencies of strategic interest to Novo Nordisk A/S. 

Latest news

• Nov 15, 2011
  Pieris announces results and successful completion of its PRS-050 Anticalin Phase I trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference
   
• Oct 19, 2011
  Pieris outlines strategic impact of six million euro EUROCALIN Grant Award on anticalin pipeline development
   
• Sep 13, 2011:
  Affimed Therapeutics implements strategic management reorganization to support new corporate strategy